Giao diện
TeguNews
Thế giới

Why patients with overlapping chronic conditions often spend years seeking answers

Delayed diagnosis, fragmented care and high treatment costs continue to burden patients with overlapping conditions such as PASH syndrome, hidradenitis suppurativa, fibromyalgia and irritable bowel syndrome, say experts

The Hindu3 phút đọc

Why patients with overlapping chronic conditions often spend years seeking answers

Thirty-year-old Rani Saranya from Kerala spent nearly eight years moving between clinics before doctors could explain why she was living with persistent pain, recurrent skin lesions, fatigue and digestive problems.Today, she has been diagnosed with PASH syndrome, a rare autoinflammatory disorder characterised by pyoderma gangrenosum, acne (a rare, non-contagious autoinflammatory skin disease) and hidradenitis suppurativa (a chronic, non-contagious skin disease causing painful, boil-like lumps, abscesses, and tunnels) along with fibromyalgia and irritable bowel syndrome (IBS). “Getting a diagnosis was a relief because it helped me understand what was happening to my body and allowed me to access more appropriate treatment and support,” she says.

The diagnoses brought clarity, but not an end to the challenges of living with multiple chronic conditions. The reality of invisible illnesses and the challenges of Crohn’s disease care in IndiaYears of symptomsMs. Saranya’s symptoms were initially treated as separate medical problems rather than manifestations of interconnected conditions.

“For many years, I experienced symptoms without knowing that they were connected. I visited multiple doctors and received different opinions, but initially the conditions were treated as separate problems rather than parts of a larger picture,” she says.The delay is not unusual.

Hidradenitis suppurativa (HS), one component of PASH syndrome, is itself frequently underdiagnosed. Global prevalence estimates vary, but large systematic reviews place HS prevalence at around 0.3% to 0.

4% of the population, while studies suggest it may affect as many as 2.5% of adults, indicating that many cases remain undetected.IBS affects an estimated 5% to 10% of people worldwide, while fibromyalgia is estimated to affect around 2% to 4% of the population globally.

Studies have shown significant overlap between the two conditions.Pandurangan Basumani, senior consultant interventional gastroenterologist and director, Kauvery Hospital, Vadapalani, Chennai, says overlap among these disorders is increasingly recognised. “Roughly one-third of patients may have more than one of these conditions at a given time,” he says.

Patients with fibromyalgia frequently have IBS, temporomandibular disorders and chronic low back pain, while people with hidradenitis suppurativa may also experience fibromyalgia, migraine, chronic fatigue syndrome and bowel disorders, he notes.The underlying mechanisms are multifactorial, involving immune-mediated inflammatory pathways, genetic susceptibility, environmental triggers and a phenomenon known as central sensitisation, where the nervous system becomes increasingly sensitive to pain signals. Study finds high rates of polypharmacy, self-medication among older adults in India The financial burdenDiagnosis apart, the cost of treatment remains a persistent challenge.

Ms. Saranya is currently on the biologic drug adalimumab, with each injection costing around ₹6,000. Depending on the severity of disease activity, she requires one or two injections a week.

In addition to medication expenses, she faces recurring costs for specialist consultations, investigations, wound care and travel for appointments. “Living with multiple chronic conditions means healthcare is not just an occasional visit to a doctor, it is an ongoing process that requires constant monitoring, planning and adjustment,” she says.At present, Ms.

Saranya says, she does not receive insurance coverage or financial assistance from the government for her conditions. She believes recognition of rare autoinflammatory disorders such as PASH syndrome within government rare disease frameworks could help improve access to financial support.Experts say such challenges are common among patients with overlapping chronic illnesses.

All you need to know about: fibromyalgiaNeed for coordinated careAccording to Dr. Basumani, medicine is gradually moving away from viewing these disorders as isolated diseases. “The paradigm shift needed is to recognise that these conditions are interlinked and overlapping.

Care should be patient-centred rather than process-centred,” he says.Dr. Basumani says integrated clinics offer same-day multidisciplinary consultations, digital tools to coordinate appointments and treatment plans, and simultaneous management of inflammation, pain and psychological health.

Arul Prakash, clinical lead and senior consultant, medical gastroenterology and hepatology, SRM Prime Hospital, Chennai, says patients with chronic inflammatory disorders frequently require input from gastroenterologists, rheumatologists, infectious disease specialists, pain clinics, psychiatrists and physiotherapists. Multidisciplinary team meetings, where specialists discuss complex cases together, are becoming more common but remain limited to a few centres. “There is room for improvement so that more patients can benefit from coordinated care,” he says.

Ms. Saranya says awareness remains the most urg

Nguồn: The Hindu

Đọc thêm từ Thế giới